We are monitoring the impact of COVID-19 on Europe Rubella Vaccine Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 6180
Share on
Share on

Europe Rubella Vaccine Market Research Report - Segmented By End User & By Country(UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) -Industry Analysis, Size, Share, Growth, Trends, And Forecasts | 2019-2024

Pulished: February, 2020
ID: 6180
Pages: 145

Europe Rubella Vaccine Market Size & Growth (2019 - 2024)

As per the research report, the size of the Europe Rubella Vaccine (Human Diploid Cell) market is valued at USD XX billion in 2019 and is expected to reach USD XX billion by 2024 at XX % CAGR during the forecast period 2019 to 2024.

Rubella is an acute, viral, and contagious infection, which has a mild effect on children and is caused by the transmission of airborne droplets of infected people through sneezing or coughing. However, pregnant women suffering from rubella have to face severe consequences, as the viral infection results in death or congenital defects known as congenital rubella syndrome (CRS). Rubella vaccine has gained traction over the years as the disease is preventable only through vaccination and no other specific treatments exist for it.

The major factors that fuel the growth of the market are an increase in the incidence of rubella infection  Approximately 100,000 infants are affected by rubella annually, thus increasing the government focus on rubella vaccination, which further propels the market growth. However, inherent disadvantages of using human diploid cell technology for constructing rubella vaccines such as high selectivity and insufficient yield, restrain the growth of the market. Conversely, ongoing R&D activities for the advancement of rubella vaccines are expected to offer lucrative opportunities for the growth of the market.

This research report segmented and sub-segmented into the following categories:

  • By End User: Pediatric Rubella Vaccine, Adult Rubella Vaccine, And Traveler Rubella Vaccine
  • By Country: UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe

Europe accounted for the second largest share of the Rubella Vaccine market.

Key players operating in the Europe Rubella Vaccine Market profiled in this report are Merck & Co., Inc., GlaxoSmithKline Plc, Chiron Corporation (Novartis), Sanofi-Aventis, Serum Institute of India, Astellas Pharma Inc., AstraZeneca Plc. (Medimmune, LLC.), CSL Limited, Pfizer Inc., and Berna Biotech (Crucell).

1. Introduction                                                 

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                          

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                               

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                           

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                      

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview                                                       

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 Epidemology                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                    

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                                              

5. Market Segmentation                                                              

                5.1 End User                                      

                                5.1.1 Introduction                           

                                5.1.2 Pediatric Rubella Vaccine                  

                                5.1.3 Adult Rubella Vaccine                         

                                5.1.4 Traveler Rubella Vaccine                   

                                5.1.5  Y-o-Y Growth Analysis, By End User                            

                                5.1.6  Market Attractiveness Analysis, By End User                          

                                5.1.7  Market Share Analysis, By End User                            

6. Geographical Analysis                                                              

                6.1 Introduction                                               

                                6.1.1 Regional Trends                    

                                6.1.2 Impact Analysis                     

                                6.1.3 Y-o-Y Growth Analysis                        

                                       By Geographical Area     

                                       By End User        

                                6.1.4  Market Attractiveness Analysis                     

                                       By Geographical Area     

                                       By End User        

                                6.1.5  Market Share Analysis                      

                                       By Geographical Area     

                                       By End User        

                6.2 U.K                                 

                6.3 Spain                                             

                6.4 Germany                                     

                6.5 Italy                                               

                6.6 France                                          

7. Strategic Analysis                                                       

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                       

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services                              

                                7.2.5 Competitive Rivalry within the Industry                     

8. Market Leaders' Analysis                                                        

                8.1 Merck & Co. Inc.                                       

                                8.1.1 Overview                 

                                8.1.2 Product Analysis                   

                                8.1.3 Financial analysis                  

                                8.1.4 Recent Developments                       

                                8.1.5 SWOT analysis                       

                                8.1.6 Analyst View                          

                8.2 GlaxoSmithKline Plc                                

                8.3 Chiron Corporation                                 

                8.4 Sanofi-Aventis                                          

                8.5 Serum Institute of India                                        

                8.6 Astellas Pharma Inc.                                               

                8.7 AstraZeneca Plc.                                       

                8.8 CSL Limited                                 

                8.9 Pfizer Inc.                                    

                8.10 Berna Biotech                                         

9. Competitive Landscape                                                           

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                       

                9.3 Agreements, collaborations and Joint Ventures                                         

                9.4 New Product Launches                                         

10. Market Outlook and Investment Opportunities                                                         


                a) List of Tables                                

                b) List of Figures                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of Region, by End user along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market


  1. Europe Rubella Vaccine  Market By End User, From 2019-2024 ( USD Million )
  2. Europe Pediatric Rubella Vaccine Market By Region, From 2019-2024 ( USD Million )
  3. Europe Adult Rubella Vaccine  Market By Region, From 2019-2024 ( USD Million )
  4. Europe Traveler Rubella Vaccine Market By Region, From 2019-2024 ( USD Million )
  5. U.K. Rubella Vaccine  Market By End User, From 2019-2024 ( USD Million )
  6. Germany Rubella Vaccine  Market By End User, From 2019-2024 ( USD Million )
  7. France Rubella Vaccine  Market By End User, From 2019-2024 ( USD Million )
  8. Italy Rubella Vaccine  Market By End User, From 2019-2024 ( USD Million )
  9. Spain Rubella Vaccine  Market By End User, From 2019-2024 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports


$ 1234 3335

Click for Request Sample